MedPath

Essential Fatty Acids in Adult ADHD

Phase 3
Completed
Conditions
Adult Attention Deficit Hyperactivity Disorder
Interventions
Dietary Supplement: Essential fatty acids
Registration Number
NCT01798381
Lead Sponsor
Universität des Saarlandes
Brief Summary

The aim of this project is to investigate the effect of a dietary supplementation with essential fatty acids in adults on cognitive functions related to attention and impulse control in the general population and in individuals with a diagnosis of attention deficit hyperactivity disorder (ADHD).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • DSM-IV ADHD
Exclusion Criteria
  • any acute psychiatric disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Essential fatty acidsEssential fatty acidsOmega-3
PlaceboEssential fatty acidsPlacebo tablet
Primary Outcome Measures
NameTimeMethod
Wender Reimherr Adult Attention Deficit Disorder Scale (WRAADDS)6 months

Psychopatholoy of adult ADHD

Secondary Outcome Measures
NameTimeMethod
Short and long interval cortical inhibition (SICI and LICI)6 months

Motoric evoced potentials by transcranial magnetic stimulation (TMS)

Trial Locations

Locations (1)

Saarland University Hospital

🇩🇪

Homburg/Saar, Saarland, Germany

© Copyright 2025. All Rights Reserved by MedPath